Sinopharm Group Co (HK:1099) has released an update.
Sinopharm Group Co. Ltd. has announced changes to its board committees’ leadership, appointing Mr. Zhao Bingxiang as chairman of both the nomination and strategy and investment committees, and as a member of the legal and compliance and environmental, social and governance committee. Additionally, Mr. Lian Wanyong has been appointed as a member of the strategy and investment committee and the legal and compliance and environmental, social and governance committee, effective from September 14, 2024.
For further insights into HK:1099 stock, check out TipRanks’ Stock Analysis page.
